Zimmer Biomet Holdings, Inc. (ZBH) Analysts See $1.87 EPS

April 12, 2018 - By reb123z

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Logo

Analysts expect Zimmer Biomet Holdings, Inc. (NYSE:ZBH) to report $1.87 EPS on April, 26.They anticipate $0.26 EPS change or 12.21 % from last quarter’s $2.13 EPS. ZBH’s profit would be $379.94 million giving it 14.18 P/E if the $1.87 EPS is correct. After having $2.10 EPS previously, Zimmer Biomet Holdings, Inc.’s analysts see -10.95 % EPS growth. The stock decreased 1.17% or $1.26 during the last trading session, reaching $106.03. About 637,441 shares traded. Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has declined 9.82% since April 12, 2017 and is downtrending. It has underperformed by 21.37% the S&P500.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Ratings Coverage

Among 21 analysts covering Zimmer Biomet Holdings (NYSE:ZBH), 14 have Buy rating, 0 Sell and 7 Hold. Therefore 67% are positive. Zimmer Biomet Holdings had 32 analyst reports since October 13, 2017 according to SRatingsIntel. The stock has “Buy” rating by Guggenheim on Wednesday, January 31. BMO Capital Markets maintained it with “Buy” rating and $144.0 target in Tuesday, January 30 report. Citigroup maintained the stock with “Neutral” rating in Tuesday, February 27 report. As per Thursday, December 21, the company rating was maintained by Jefferies. On Thursday, November 2 the stock rating was maintained by Morgan Stanley with “Overweight”. The firm has “Neutral” rating by Robert W. Baird given on Friday, March 23. The firm earned “Buy” rating on Thursday, October 26 by Needham. The firm has “Buy” rating by BMO Capital Markets given on Wednesday, November 1. The firm has “Buy” rating by Robert W. Baird given on Tuesday, January 30. On Thursday, January 4 the stock rating was maintained by Canaccord Genuity with “Hold”.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, makes, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company has market cap of $21.54 billion. It operates through four divisions: Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic , and Dental. It has a 11.91 P/E ratio. The firm provides orthopedic reconstructive products, such as knee and hip reconstructive products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: